Literature DB >> 28138637

Impact of pathologic tumor response in the treatment of gastric cancer.

Joyce Wong1.   

Abstract

Entities:  

Year:  2016        PMID： 28138637      PMCID： PMC5244616          DOI： 10.21037/tgh.2016.09.04

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  10 in total

1.  Tumor regression grade in gastric cancer: Predictors and impact on outcome.

Authors:  Aaron U Blackham; Erin Greenleaf; Maki Yamamoto; Chris Hollenbeak; Niraj Gusani; Domenico Coppola; Jose M Pimiento; Joyce Wong
Journal:  J Surg Oncol       Date:  2016-05-20       Impact factor: 3.454

2.  Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.

Authors:  A M Mandard; F Dalibard; J C Mandard; J Marnay; M Henry-Amar; J F Petiot; A Roussel; J H Jacob; P Segol; G Samama
Journal:  Cancer       Date:  1994-06-01       Impact factor: 6.860

3.  Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.

Authors:  T Glatz; P Bronsert; M Schäfer; B Kulemann; G Marjanovic; O Sick; U T Hopt; K Zirlik; F Makowiec; J Hoeppner
Journal:  Eur J Surg Oncol       Date:  2015-07-29       Impact factor: 4.424

4.  Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.

Authors:  Karen Becker; James D Mueller; Christoph Schulmacher; Katja Ott; Ulrich Fink; Raymonde Busch; Knut Böttcher; J Rüdiger Siewert; Heinz Höfler
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

5.  Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?

Authors:  John C Mansour; Laura Tang; Manish Shah; David Bentrem; David S Klimstra; Mithat Gonen; David P Kelsen; Murray F Brennan; Daniel G Coit
Journal:  Ann Surg Oncol       Date:  2007-10-02       Impact factor: 5.344

6.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

7.  Tumor regression and survival after perioperative MAGIC-style chemotherapy in carcinoma of the stomach and gastroesophageal junction.

Authors:  Fernando Mingol; Javier Gallego; Albina Orduña; Amparo Martinez-Blasco; Javier Sola-Vera; Pedro Moya; Miguel Angel Morcillo; Juan Antonio Ruiz; Rafael Calpena; Francisco-Javier Lacueva
Journal:  BMC Surg       Date:  2015-05-22       Impact factor: 2.102

Review 8.  Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment.

Authors:  Svenja Thies; Rupert Langer
Journal:  Front Oncol       Date:  2013-10-07       Impact factor: 6.244

9.  Japanese gastric cancer treatment guidelines 2014 (ver. 4).

Authors: 
Journal:  Gastric Cancer       Date:  2016-06-24       Impact factor: 7.370

10.  Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial.

Authors:  Elizabeth C Smyth; Matteo Fassan; David Cunningham; William H Allum; Alicia F C Okines; Andrea Lampis; Jens C Hahne; Massimo Rugge; Clare Peckitt; Matthew Nankivell; Ruth Langley; Michele Ghidini; Chiara Braconi; Andrew Wotherspoon; Heike I Grabsch; Nicola Valeri
Journal:  J Clin Oncol       Date:  2016-06-13       Impact factor: 44.544
  10 in total
  2 in total

1.  Which is the optimal management for locally advanced gastric cancer patients with TRG 0 and 1 after R0 resection?

Authors:  Fei Ma; Yonglei Zhang; Liangqun Peng; Zhandong Zhang; Wei Yang; Junhui Chai; Bin Zhang; Sheqing Ji; Yawei Hua; Xiaobing Chen; Suxia Luo
Journal:  Ann Transl Med       Date:  2020-08

Review 2.  Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.

Authors:  Dustin J Flanagan; Elizabeth Vincan; Toby J Phesse
Journal:  Br J Pharmacol       Date:  2017-07-05       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.